ABSTRACT
Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify candidate molecular mediators of muscle atrophy, we performed transcript profiling. Although many genes were up-regulated in a single rat model of atrophy, only a small subset was universal in all atrophy models. Two of these genes encode ubiquitin ligases: Muscle RING Finger 1 (MuRF1), and a gene we designate Muscle Atrophy F-box (MAFbx), the latter being a member of the SCF family of E3 ubiquitin ligases. Overexpression of MAFbx in myotubes produced atrophy, whereas mice deficient in either MAFbx or MuRF1 were found to be resistant to atrophy. These proteins are potential drug targets for the treatment of muscle atrophy.
Subject(s)
DNA-Binding Proteins , Gene Expression Profiling , Muscle, Skeletal/metabolism , Muscular Atrophy/genetics , Peptide Synthases/metabolism , Trans-Activators , Amino Acid Sequence , Animals , Cloning, Molecular , Creatine Kinase/genetics , Creatine Kinase, MM Form , Gene Deletion , Hindlimb Suspension , Humans , Immobilization , Isoenzymes/genetics , Mice , Mice, Knockout , Molecular Sequence Data , Muscle Denervation , Muscle Proteins/genetics , Muscle, Skeletal/growth & development , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Muscular Atrophy/pathology , Muscular Atrophy/physiopathology , MyoD Protein/genetics , Myogenic Regulatory Factor 5 , Myogenin/genetics , Peptide Synthases/chemistry , Peptide Synthases/deficiency , Peptide Synthases/genetics , Phenotype , Protein Binding , RNA, Messenger/analysis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , SKP Cullin F-Box Protein Ligases , Up-RegulationABSTRACT
Growing axons follow highly stereotypical pathways, guided by a variety of attractive and repulsive cues, before establishing specific connections with distant targets. A particularly well-known example that illustrates the complexity of axonal migration pathways involves the axonal projections of motor neurons located in the motor cortex. These projections take a complex route during which they first cross the midline, then form the corticospinal tract, and ultimately connect with motor neurons in the contralateral side of the spinal cord. These obligatory contralateral connections account for why one side of the brain controls movement on the opposing side of the body. The netrins and slits provide well-known midline signals that regulate axonal crossings at the midline. Herein we report that a member of the ephrin family, ephrin-B3, also plays a key role at the midline to regulate axonal crossing. In particular, we show that ephrin-B3 acts as the midline barrier that prevents corticospinal tract projections from recrossing when they enter the spinal gray matter. We report that in ephrin-B3(-/-) mice, corticospinal tract projections freely recross in the spinal gray matter, such that the motor cortex on one side of the brain now provides bilateral input to the spinal cord. This neuroanatomical abnormality in ephrin-B3(-/-) mice correlates with loss of unilateral motor control, yielding mice that simultaneously move their right and left limbs and thus have a peculiar hopping gait quite unlike the alternate step gait displayed by normal mice. The corticospinal and walking defects in ephrin-B3(-/-) mice resemble those recently reported for mice lacking the EphA4 receptor, which binds ephrin-B3 as well as other ephrins, suggesting that the binding of EphA4-bearing axonal processes to ephrin-B3 at the midline provides the repulsive signal that prevents corticospinal tract projections from recrossing the midline in the developing spinal cord.
Subject(s)
Axons/ultrastructure , Functional Laterality/physiology , Membrane Proteins/physiology , Motor Activity/physiology , Movement Disorders/genetics , Pyramidal Tracts/ultrastructure , Receptor Protein-Tyrosine Kinases/physiology , Animals , Ephrin-B3 , Functional Laterality/genetics , Gait , Grooming , Male , Membrane Proteins/deficiency , Membrane Proteins/genetics , Mice , Mice, Knockout , Mice, Neurologic Mutants , Morphogenesis , Movement Disorders/embryology , Movement Disorders/physiopathology , Postural Balance , Pyramidal Tracts/embryology , Pyramidal Tracts/physiopathology , Receptor, EphB4 , Receptors, Eph Family , Sensation Disorders/embryology , Sensation Disorders/genetics , Sensation Disorders/physiopathology , Single-Blind MethodSubject(s)
Gene Targeting/methods , Stem Cells , Animals , Cell Culture Techniques , Humans , Stem Cells/cytologyABSTRACT
The Eph receptor tyrosine kinases and their membrane-tethered ephrin ligands provide critical guidance cues at points of cell-to-cell contact. It has recently been reported that the ephrin-B2 ligand is a molecular marker for the arterial endothelium at the earliest stages of embryonic angiogenesis, while its receptor EphB4 reciprocally marks the venous endothelium. These findings suggested that ephrin-B2 and EphB4 are involved in establishing arterial versus venous identity and perhaps in anastamosing arterial and venous vessels at their junctions. By using a genetically engineered mouse in which the lacZ coding region substitutes and reports for the ephrin-B2 coding region, we demonstrate that ephrin-B2 expression continues to selectively mark arteries during later embryonic development as well as in the adult. However, as development proceeds, we find that ephrin-B2 expression progressively extends from the arterial endothelium to surrounding smooth muscle cells and to pericytes, suggesting that ephrin-B2 may play an important role during formation of the arterial muscle wall. Furthermore, although ephrin-B2 expression patterns vary in different vascular beds, it can extend into capillaries about midway between terminal arterioles and postcapillary venules, challenging the classical conception that capillaries have neither arterial nor venous identity. In adult settings of angiogenesis, as in tumors or in the female reproductive system, the endothelium of a subset of new vessels strongly expresses ephrin-B2, once again contrary to earlier views that such new vessels lack arterial/venous characteristics and derive from postcapillary venules. While earlier studies had focused on a role for ephrin-B2 during the earliest embryonic stages of arterial/venous determination, our current findings using ephrin-B2 as an arterial marker in the adult challenge prevailing views of the arterial/venous identity of quiescent as well as remodeling adult microvessels and also highlight a possible role for ephrin-B2 in the formation of the arterial muscle wall.
Subject(s)
Arteries/metabolism , Endothelium, Vascular/metabolism , Lung Neoplasms/blood supply , Membrane Proteins/genetics , Muscle, Smooth, Vascular/metabolism , Neovascularization, Pathologic/metabolism , Animals , Arterioles/metabolism , Biomarkers , Capillaries/metabolism , Endothelium, Vascular/pathology , Ephrin-B2 , Gene Expression Regulation , Membrane Proteins/analysis , Mice , Mice, Transgenic , Muscle, Smooth, Vascular/pathology , Neovascularization, Pathologic/pathology , Organ Specificity , Venules/metabolism , beta-Galactosidase/geneticsABSTRACT
Receptor tyrosine kinases often have critical roles in particular cell lineages by initiating signalling cascades in those lineages. Examples include the neural-specific TRK receptors, the VEGF and angiopoietin endothelial-specific receptors, and the muscle-specific MUSK receptor. Many lineage-restricted receptor tyrosine kinases were initially identified as 'orphans' homologous to known receptors, and only subsequently used to identify their unknown growth factors. Some receptor-tyrosine-kinase-like orphans still lack identified ligands as well as biological roles. Here we characterize one such orphan, encoded by Ror2 (ref. 12). We report that disruption of mouse Ror2 leads to profound skeletal abnormalities, with essentially all endochondrally derived bones foreshortened or misshapen, albeit to differing degrees. Further, we find that Ror2 is selectively expressed in the chondrocytes of all developing cartilage anlagen, where it essential during initial growth and patterning, as well as subsequently in the proliferating chondrocytes of mature growth plates, where it is required for normal expansion. Thus, Ror2 encodes a receptor-like tyrosine kinase that is selectively expressed in, and particularly important for, the chondrocyte lineage.
Subject(s)
Abnormalities, Multiple/genetics , Bone and Bones/abnormalities , Cartilage/embryology , Growth Plate/embryology , Receptor Protein-Tyrosine Kinases/physiology , Receptors, Cell Surface/physiology , Abnormalities, Multiple/embryology , Amino Acid Sequence , Animals , Cartilage/abnormalities , Cell Lineage , Chondrocytes/metabolism , Embryonic and Fetal Development/genetics , Fetal Proteins/deficiency , Fetal Proteins/genetics , Fetal Proteins/physiology , Gene Targeting , Genes, Reporter , In Situ Hybridization , Mice , Mice, Knockout , Molecular Sequence Data , Morphogenesis/genetics , Phenotype , Receptor Protein-Tyrosine Kinases/deficiency , Receptor Protein-Tyrosine Kinases/genetics , Receptor Tyrosine Kinase-like Orphan Receptors , Receptors, Cell Surface/deficiency , Receptors, Cell Surface/genetics , Recombinant Fusion Proteins/physiology , Signal TransductionABSTRACT
Inherited limb malformations provide a valuable resource for the identification of genes involved in limb development. Brachydactyly type B (BDB), an autosomal dominant disorder, is the most severe of the brachydactylies and characterized by terminal deficiency of the fingers and toes. In the typical form of BDB, the thumbs and big toes are spared, sometimes with broadening or partial duplication. The BDB1 locus was previously mapped to chromosome 9q22 within an interval of 7.5 cM (refs 9,10). Here we describe mutations in ROR2, which encodes the orphan receptor tyrosine kinase ROR2 (ref. 11), in three unrelated families with BDB1. We identified distinct heterozygous mutations (2 nonsense, 1 frameshift) within a 7-amino-acid segment of the 943-amino-acid protein, all of which predict truncation of the intracellular portion of the protein immediately after the tyrosine kinase domain. The localized nature of these mutations suggests that they confer a specific gain of function. We obtained further evidence for this by demonstrating that two patients heterozygous for 9q22 deletions including ROR2 do not exhibit BDB. Expression of the mouse mouse orthologue, Ror2, early in limb development indicates that BDB arises as a primary defect of skeletal patterning.
Subject(s)
Fingers/abnormalities , Genes, Dominant , Receptor Protein-Tyrosine Kinases/genetics , Receptors, Cell Surface/genetics , Amino Acid Sequence , Animals , Chromosomes, Human, Pair 9/genetics , Female , Fingers/embryology , Frameshift Mutation , Heterozygote , Humans , Male , Mice , Mice, Knockout , Molecular Sequence Data , Pedigree , Phenotype , Receptor Protein-Tyrosine Kinases/deficiency , Receptor Tyrosine Kinase-like Orphan Receptors , Receptors, Cell Surface/deficiency , Sequence DeletionABSTRACT
Differentiation of the postsynaptic membrane at the neuromuscular junction requires agrin, a nerve-derived signal; MuSK, a critical component of the agrin receptor in muscle; and rapsyn, a protein that interacts with acetylcholine receptors (AChRs). We showed previously that nerve-induced AChR aggregation is dramatically impaired in knockout mice lacking agrin, MuSK, or rapsyn. However, the phenotypes of these mutants differed in several respects, suggesting that the pathway from agrin to MuSK to rapsyn is complex. Here, we compared the effects of these mutations on two aspects of synaptic differentiation: AChR clustering and transcriptional specialization of synapse-associated myonuclei. First, we show that a plant lectin, VVA-B4, previously shown to act downstream of agrin, can induce AChR clusters on MuSK-deficient but not rapsyn-deficient myotubes in culture. Thus, although both MuSK and rapsyn are required for AChR clustering in vivo, only rapsyn is essential for cluster formation per se. Second, we show that neuregulin, a nerve-derived inducer of AChR gene expression, activates AChR gene expression in cultured agrin- and MuSK-deficient myotubes, even though synapse-specific transcriptional specialization is disrupted in agrin and MuSK mutants in vivo. We propose that agrin works through MuSK to determine a synaptogenic region within which synaptic differentiation occurs.
Subject(s)
Agrin/physiology , Muscle Proteins/physiology , Receptors, Growth Factor/physiology , Receptors, Nicotinic/physiology , Agrin/deficiency , Agrin/genetics , Animals , Cells, Cultured , Crosses, Genetic , Heterozygote , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Inbred Strains , Mice, Knockout , Mice, Transgenic , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/physiology , Muscle Proteins/deficiency , Muscle Proteins/genetics , Muscle, Skeletal/cytology , Muscle, Skeletal/physiology , Mutagenesis , Phenotype , Receptors, Cholinergic/genetics , Receptors, Cholinergic/physiology , Receptors, Growth Factor/deficiency , Receptors, Growth Factor/genetics , Receptors, Nicotinic/deficiency , Receptors, Nicotinic/genetics , beta-Galactosidase/geneticsABSTRACT
The impact of the nerve growth factor (NGF) family of neurotrophins and their receptors was examined on the cutaneous innervation in the mystacial pads of mice. Ten sets of unmyelinated and thinly myelinated sensory and autonomic innervation were evaluated that terminated in the epidermis, upper dermis, and upper part of the intervibrissal hair follicles. Mystacial pads were analyzed from newborn to 4-week-old mice that had homozygous functional deletions of the genes for NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4), tyrosine kinase (trk) A, trkB, trkC, or p75. Mystacial pads were also analyzed in adult transgenic mice that had overproduction of NGF, BDNF, or NT-3 driven by a keratin promoter gene. The innervation was revealed by using immunofluorescence and immunocytochemistry with antibodies for protein gene product (PGP) 9.5, calcitonin gene-related product (CGRP), substance P (SP), galanin (GAL), neuropeptide Y (NPY), tyrosine hydroxylase (TH), and a neurofilament protein. The cumulative results indicated that NGF/trkA signaling plays a major role in the outgrowth and proliferation of sensory axons, whereas NT-3/ trkA signaling plays a major role in the formation of sensory endings. TrkC is also essential for the development of three sets of trkA-dependent sensory innervation that coexpress CGRP, SP, and GAL. Another set of sensory innervation that only coexpressed CGRP and SP was solely dependent upon NGF and trkA. Surprisingly, most sets of trkA-dependent sensory innervation are suppressed by trkB perhaps interacting with p75. BDNF and NT-4 appear to mediate this suppressing effect in the upper dermis and NT-4 in the epidermis. In contrast to sensory innervation, sympathetic innervation to the necks of intervibrissal hair follicles depends upon NGF/trkA signaling interacting with p75 for both the axon outgrowth and ending formation. Although NT-3/trkA signaling is essential for the full complement of sympathetic neurons, NT-3 is detrimental to the formation of sympathetic terminations to the necks of hair follicles. TrkB signaling mediated by BDNF but not NT-4 also suppresses these sympathetic terminations. One sparse set of innervation, perhaps parasympathetic, terminating at the necks of hair follicles is dependent solely upon NT-3 and trkC. Taken together, our results indicate that the innervation of the epidermis, upper dermis, and the upper portion of hair follicles is regulated by a competitive balance between promoting and suppressing effects of the various neurotrophins.
Subject(s)
Nerve Growth Factors/physiology , Receptor Protein-Tyrosine Kinases/physiology , Skin/innervation , Animals , Fluorescent Antibody Technique , Gene Expression Regulation, Developmental/genetics , Immunohistochemistry , Mice , Mice, Knockout , Nerve Growth Factors/genetics , Neurotrophin 3 , Receptor, Nerve Growth Factor , Receptor, trkA/genetics , Receptor, trkA/physiology , Receptors, Nerve Growth Factor , Signal Transduction/physiology , Skin/cytologyABSTRACT
The impact of null mutations of the genes for the NGF family of neurotrophins and their receptors was examined among the wide variety of medium to large caliber myelinated mechanoreceptors which have a highly specific predictable organization in the mystacial pad of mice. Immunofluorescence with anti-protein gene product 9.5, anti-200-kDa neurofilament protein (RT97), and anti-calcitonin gene-related product was used to label innervation in mystacial pads from mice with homozygous null mutations for nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4), the three tyrosine kinase receptors (trkA, trkB, trkC), and the low-affinity nerve growth factor receptor p75. Specimens were sacrificed at birth and at 1, 2, and 4 weeks for each type of mutation as well as at 11 weeks and 1 year for p75 and trkC mutations, respectively. Our results demonstrate several major concepts about the role of neurotrophins in the development of cutaneous mechanoreceptors that are supplied by medium to large caliber myelinated afferents. First, each of the high-affinity tyrosine kinase receptors, trkA, trkB, and trkC, as well as the low-affinity p75 receptor has an impact on at least one type of mechanoreceptor. Second, consistent with the various affinities for particular trk receptors, the elimination of NGF, BDNF, and NT-3 has an impact comparable to or more complex than the absence of their most specific high-affinity receptors: trkA, trkB, and trkC, respectively. These complexities include potential NT-3 signaling through trkA and trkB to support some neuronal survival. Third, most types of afferents are dependent on a different combination of neurotrophins and receptors for their survival: reticular and transverse lanceolate afferents are dependent upon NT-3, NGF, and trkA; Ruffini afferents upon BDNF and trkB; longitudinal lanceolate afferents upon NGF, trkA, BDNF, and trkB; and Merkel afferents on NGF, trkA, NT-3, trkC, and p75. NT-4 has no obvious detrimental impact on the mechanoreceptor development in the presence of BDNF. Fourth, NT-4 and BDNF signaling through trkB may suppress Merkel innervation and NT-3 signaling through trkC may suppress Ruffini innervation. Finally, regardless of the neurotrophin/receptor dependency for afferent survival and neurite outgrowth, NT-3 has an impact on the formation of all the sensory endings. In the context of these findings, indications of competitive and suppressive interactions that appear to regulate the balance of innervation density among the various sets of innervation were evident.
Subject(s)
Mechanoreceptors , Nerve Growth Factors/physiology , Receptor Protein-Tyrosine Kinases/physiology , Receptors, Nerve Growth Factor/physiology , Skin/innervation , Animals , Axons , Epidermis/innervation , Merkel Cells , Mice , Mice, Knockout , Mutation , Nerve Growth Factors/genetics , Neurons, Afferent , Receptor Protein-Tyrosine Kinases/genetics , Receptors, Nerve Growth Factor/genetics , Vibrissae/innervation , Vibrissae/metabolismABSTRACT
Formation of the neuromuscular junction (NMJ) depends upon a nerve-derived protein, agrin, acting by means of a muscle-specific receptor tyrosine kinase, MuSK, as well as a required accessory receptor protein known as MASC. We report that MuSK does not merely play a structural role by demonstrating that MuSK kinase activity is required for inducing acetylcholine receptor (AChR) clustering. We also show that MuSK is necessary, and that MuSK kinase domain activation is sufficient, to mediate a key early event in NMJ formation-phosphorylation of the AChR. However, MuSK kinase domain activation and the resulting AChR phosphorylation are not sufficient for AChR clustering; thus we show that the MuSK ectodomain is also required. These results indicate that AChR phosphorylation is not the sole trigger of the clustering process. Moreover, our results suggest that, unlike the ectodomain of all other receptor tyrosine kinases, the MuSK ectodomain plays a required role in addition to simply mediating ligand binding and receptor dimerization, perhaps by helping to recruit NMJ components to a MuSK-based scaffold.
Subject(s)
Muscle, Skeletal/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Cholinergic/metabolism , Agrin/metabolism , Animals , Cell Line , Humans , Phosphorylation , Rats , Receptor Aggregation , Receptor Protein-Tyrosine Kinases/genetics , Recombinant Fusion Proteins/metabolismABSTRACT
Ciliary neurotrophic factor (CNTF) has potent survival-promoting effects on motoneurons in vitro and in vivo. We examined knockout mice with null mutations of the gene for either CNTF itself or the alpha-subunit of the CNTF receptor (CNTFRalpha) to assess whether CNTF and/or its receptors are involved in the development of a sexually dimorphic neuromuscular system. Male rodents have many more motoneurons in the spinal nucleus of the bulbocavernosus (SNB) than do females. This sex difference is caused by hormone-regulated death of SNB motoneurons and their target muscles. Sexual dimorphism of SNB motoneuron number developed completely normally in CNTF knockout (CNTF -/-) mice. In contrast, a sex difference in the SNB was absent in CNTFRalpha -/- animals: male mice lacking a functional CNTF alpha-receptor had fewer than half as many SNB motoneurons than did wild-type males and no more than did their female counterparts. Size of the bulbocavernosus and levator ani muscles, the main targets of SNB motoneurons, was not affected in either CNTF or CNTFRalpha knockout males. These observations suggest that signaling through the CNTF receptor is involved in sexually dimorphic development of SNB motoneuron number and that target muscle survival per se is not sufficient to ensure motoneuron survival in this system. In addition, our observations are consistent with the suggestion that CNTF itself is not the only endogenous ligand for the CNTF receptor. A second, as yet unknown, ligand may be important for neural development, including sexually dimorphic motoneuron development.
Subject(s)
Motor Neurons/chemistry , Nerve Tissue Proteins/genetics , Sex Characteristics , Spinal Cord/cytology , Androgens/physiology , Animals , Cell Count , Cell Size , Ciliary Neurotrophic Factor , Female , Gene Deletion , Male , Mice , Mice, Knockout , Motor Neurons/cytology , Muscle Development , Muscle, Skeletal/growth & development , Muscle, Skeletal/innervation , Nerve Growth Factors/deficiency , Nerve Growth Factors/genetics , Nerve Tissue Proteins/deficiency , Receptor Protein-Tyrosine Kinases/genetics , Receptor, Ciliary Neurotrophic Factor , Receptors, Nerve Growth Factor/geneticsABSTRACT
Formation of neuromuscular synapses requires a series of inductive interactions between growing motor axons and differentiating muscle cells, culminating in the precise juxtaposition of a highly specialized nerve terminal with a complex molecular structure on the postsynaptic muscle surface. The receptors and signaling pathways mediating these inductive interactions are not known. We have generated mice with a targeted disruption of the gene encoding MuSK, a receptor tyrosine kinase selectively localized to the postsynaptic muscle surface. Neuromuscular synapses do not form in these mice, suggesting a failure in the induction of synapse formation. Together with the results of an accompanying manuscript, our findings indicate that MuSK responds to a critical nerve-derived signal (agrin), and in turn activates signaling cascades responsible for all aspects of synapse formation, including organization of the postsynaptic membrane, synapse-specific transcription, and presynaptic differentiation.
Subject(s)
Neuromuscular Junction/chemistry , Receptor Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases/physiology , Agrin/physiology , Animals , Animals, Newborn , Cell Differentiation/genetics , Gene Deletion , Gene Expression/physiology , Genes, Lethal/physiology , Mice , Mice, Knockout , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/ultrastructure , Muscle, Skeletal/chemistry , Muscle, Skeletal/embryology , Muscle, Skeletal/innervation , Neuromuscular Junction/embryology , Neuromuscular Junction/physiology , Receptors, Cholinergic/genetics , Signal Transduction/physiology , Synapses/chemistry , Synapses/physiology , Synaptic Membranes/physiology , Transcription, Genetic/physiologyABSTRACT
Formation of th neuromuscular junction depends upon reciprocal inductive interactions between the developing nerve and muscle, resulting in the precise juxtaposition of a differentiated nerve terminal with a highly specialized patch on the muscle membrane, termed the motor endplate. Agrin is a nerve-derived factor that can induced molecular reorganizations at the motor endplate, but the mechanism of action of agrin remains poorly understood. MuSK is a receptor tyrosine kinase localized to the motor endplate, seemingly well positioned to receive a key nerve-derived signal. Mice lacking either agrin or MuSK have recently been generated and exhibit similarly profound defects in their neuromuscular junctions. Here we demonstrate that agrin acts via a receptor complex that includes MuSK as well as a myotube-specific accessory component.
Subject(s)
Agrin/genetics , Receptor Protein-Tyrosine Kinases/genetics , Signal Transduction/physiology , Agrin/metabolism , Animals , Gene Deletion , Gene Expression/physiology , Mice , Mice, Knockout , Muscle Fibers, Skeletal/physiology , Muscle Fibers, Skeletal/ultrastructure , Muscle, Skeletal/cytology , Muscle, Skeletal/embryology , Muscle, Skeletal/physiology , Neuromuscular Junction/chemistry , Neuromuscular Junction/embryology , Neuromuscular Junction/physiology , Phosphorylation , Protein Structure, Tertiary , Receptor Protein-Tyrosine Kinases/chemistry , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Cholinergic/physiology , Tyrosine/metabolismSubject(s)
Agrin/metabolism , Neuromuscular Junction/physiology , Receptor Protein-Tyrosine Kinases/genetics , Animals , Humans , Mice , Receptor Protein-Tyrosine Kinases/physiology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Signal Transduction/genetics , Signal Transduction/physiologyABSTRACT
Ciliary neurotrophic factor (CNTF) supports motor neuron survival in vitro and in mouse models of motor neuron degeneration and was considered a candidate for the muscle-derived neurotrophic activity that regulates motor neuron survival during development. However, CNTF expression is very low in the embryo, and CNTF gene mutations in mice or human do not result in notable abnormalities of the developing nervous system. We have generated and directly compared mice containing null mutations in the genes encoding CNTF or its receptor (CNTFR alpha). Unlike mice lacking CNTF, mice lacking CNTFR alpha die perinatally and display severe motor neuron deficits. Thus, CNTFR alpha is critical for the developing nervous system, most likely by serving as a receptor for a second, developmentally important, CNTF-like ligand.
Subject(s)
Central Nervous System/abnormalities , Motor Neurons/pathology , Nerve Growth Factors/deficiency , Nerve Tissue Proteins/deficiency , Receptors, Nerve Growth Factor/deficiency , Animals , Brain Stem/abnormalities , Cell Count , Cell Survival , Ciliary Neurotrophic Factor , Efferent Pathways/abnormalities , Efferent Pathways/growth & development , Genes, Lethal , Ligands , Mice , Mice, Mutant Strains , Nerve Growth Factors/genetics , Nerve Tissue Proteins/genetics , Receptor, Ciliary Neurotrophic Factor , Receptors, Nerve Growth Factor/genetics , Spinal Cord/abnormalitiesABSTRACT
During the initial phase of their development, sensory neurons of the dorsal root ganglion (DRG) require target-derived trophic support for their survival, but as they mature they lose this requirement. Because many of these neurons express BDNF (brain-derived neurotrophic factor) messenger RNA, we hypothesized that BDNF might act as an autocrine survival factor in adult DRG neurons, thus explaining their lack of dependence on exogenous growth factors. When cultured adult DRG cells were treated with antisense oligonucleotides to BDNF, expression of BDNF protein was reduced by 80%, and neuronal survival was reduced by 35%. These neurons could be rescued by exogenous BDNF or neurotrophin-3, but not by other growth factors. Similar results were obtained with single-neuron microcultures, whereas microcultures derived from mutant mice lacking BDNF were unaffected by antisense oligonucleotides. Our results strongly support an autocrine role for BDNF in mediating the survival of a subpopulation of adult DRG neurons.
Subject(s)
Cell Death , Nerve Tissue Proteins/physiology , Neurons, Afferent/physiology , Aging , Animals , Brain-Derived Neurotrophic Factor , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured , Ganglia, Spinal/cytology , Mice , Nerve Tissue Proteins/genetics , Oligonucleotides, Antisense/pharmacology , Polysaccharides/pharmacology , RNA, Messenger/metabolismABSTRACT
Fibroblast growth factors (FGFs) are thought to influence many processes in vertebrate development because of their diverse sites of expression and wide range of biological activities in in vitro culture systems. As a means of elucidating embryonic functions of FGF-4, gene targeting was used to generate mice harboring a disrupted Fgf4 gene. Embryos homozygous for the null allele underwent uterine implantation and induced uterine decidualization but did not develop substantially thereafter. As was consistent with their behavior in vivo, Fgf4 null embryos cultured in vitro displayed severely impaired proliferation of the inner cell mass, whereas growth and differentiation of the inner cell mass were rescued when null embryos were cultured in the presence of FGF-4 protein.
Subject(s)
Embryonic Development/physiology , Embryonic and Fetal Development/physiology , Fibroblast Growth Factors/physiology , Proto-Oncogene Proteins/physiology , Animals , Base Sequence , Blastocyst/cytology , Blastocyst/physiology , Crosses, Genetic , Culture Techniques , Female , Fibroblast Growth Factor 4 , Fibroblast Growth Factors/genetics , Fibroblast Growth Factors/pharmacology , Gene Targeting , Heterozygote , Male , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Morula/drug effects , Morula/physiology , Phenotype , Pregnancy , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/pharmacology , Recombinant Proteins/pharmacologyABSTRACT
Ciliary neurotrophic factor was discovered based on its ability to support the survival of ciliary neurons, and is now known to act on a variety of neuronal and glial populations. Two distant relatives of ciliary neurotrophic factor, leukemia inhibitory factor and oncostatin M, mimic ciliary neurotrophic factor with respect to its actions on cells of the nervous system. In contrast to ciliary neurotrophic factor, leukemia inhibitory factor and oncostatin M also display a broad array of actions on cells outside of the nervous system. The overlapping activities of leukemia inhibitory factor, oncostatin M and ciliary neurotrophic factor can be attributed to shared receptor components. The specificity of ciliary neurotrophic factor for cells of the nervous system results from the restricted expression of the alpha component of the ciliary neurotrophic factor receptor complex, which is required to convert a functional leukemia inhibitory factor/oncostatin M receptor complex into a ciliary neurotrophic factor receptor complex. The recent observation that the alpha component of the ciliary neurotrophic factor receptor complex is expressed by very early neuronal precursors suggested that ciliary neurotrophic factor may act on even earlier precursors, particularly on cells previously thought to be targets for leukemia inhibitory factor action. Here we show the first example of ciliary neurotrophic factor responsiveness in cells residing outside of the nervous system by demonstrating that embryonic stem cells express a functional ciliary neurotrophic factor receptor complex, and that ciliary neurotrophic factor is similar to leukemia inhibitory factor in its ability to maintain the pluripotentiality of these cells.
Subject(s)
Interleukin-6 , Nerve Growth Factors/physiology , Nerve Tissue Proteins/physiology , Stem Cells/physiology , Animals , Blotting, Northern , Cell Differentiation/physiology , Cell Line , Ciliary Neurotrophic Factor , Cytokines/physiology , Growth Inhibitors/physiology , Leukemia Inhibitory Factor , Lymphokines/physiology , Mice , Morpholines/metabolism , Oncostatin M , Peptides/physiology , Receptor, Ciliary Neurotrophic Factor , Receptors, Growth Factor/physiology , Stem Cells/cytology , Transplantation ChimeraABSTRACT
We are studying mice that carry a targeted disruption of the gene encoding insulin-like growth factor II (IGF-II). Transmission of this mutation through the male germline results in heterozygous progeny that are growth deficient. In contrast, when the disrupted gene is transmitted maternally, the heterozygous offspring are phenotypically normal. Therefore, the difference in growth phenotypes depends on the type of gamete contributing the mutated allele. Homozygous mutants are indistinguishable in appearance from growth-deficient heterozygous siblings. Nuclease protection and in situ hybridization analyses of the transcripts from the wild-type and mutated alleles indicate that only the paternal allele is expressed in embryos, while the maternal allele is silent. An exception is the choroid plexus and leptomeninges, where both alleles are transcriptionally active. These results demonstrate that IGF-II is indispensable for normal embryonic growth and that the IGF-II gene is subject to tissue-specific parental imprinting.
Subject(s)
Genes , Insulin-Like Growth Factor II/genetics , Mutation , Animals , Chimera , Crosses, Genetic , Female , Genetic Carrier Screening , Insulin-Like Growth Factor II/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Mutant Strains , Nucleic Acid Hybridization , Pedigree , Reference ValuesABSTRACT
Growth factors are thought to function as pivotal autocrine-paracrine regulatory signals during embryonic development. Insulin-like growth factor II (IGF-II), a mitogenic polypeptide for a variety of cell lines, could have such a role, as indicated by the pattern of expression of its gene during rodent development. The IGF-II gene uses at least three promoters and expresses several transcripts in many tissues during the embryonic and neonatal periods, whereas expression in adult animals is confined to the choroid plexus and the leptomeninges. To examine the developmental role of IGF-II, we have begun to study the consequences of introducing mutations at the IGF-II gene locus in the mouse germ line. We have disrupted one of the IGF-II alleles in cultured mouse embryonic stem (ES) cells by gene targeting and constructed chimaeric animals. Germ-line transmission of the inactivated IGF-II gene from male chimaeras yielded heterozygous progeny that were smaller than their ES cell-derived wild-type littermates (about 60% of normal body weight). These growth-deficient animals were otherwise apparently normal and fertile. The effect of the mutation was exerted during the embryonic period. These results provide the first direct evidence for a physiological role of IGF-II in embryonic growth.